Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinlian Tongfeng Granule is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of gout, particularly during the remission phase of gouty arthritis. It is a complex herbal preparation, typically containing extracts from herbs such as *Artemisia capillaris*, *Coptis chinensis*, and *Smilax glabra*. The granules exert anti-inflammatory and analgesic effects by inhibiting the NF-κB signaling pathway and modulating the expression of inflammatory mediators, including PTGS2 (COX-2), TNF, IL-6, and IL-10. Research conducted at the Yueyang Hospital of Integrated Traditional and Western Medicine indicates that the formulation promotes uric acid excretion and reduces serum uric acid levels, thereby preventing gout flares.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinlian Tongfeng Granule.